Kevin Cognetti
Seminars
Wednesday 29th July 2026
Pharma Search & Evaluation Panel: Understanding the Role of In Vivo Therapeutic in Shifting Investment & Acquisition Strategies
4:30 pm
- Assessing how investors and pharma teams are integrating in vivo approaches into evolving pipeline and portfolio strategies
- Identifying the evidence and value inflection points shaping investment decisions for in vivo cell and gene therapy programs
- Aligning milestones, data packages and deal structures with shifting search, evaluation and investment priorities across the sector
Wednesday 29th July 2026
Biopharma Leaders Fireside Chat: Clinical Reflections on the Past Year & Positioning In Vivo Cell & Gene Therapies in Pharma Portfolios
9:00 am
- Distilling the past year’s clinical and translational progress into portfolio-relevant proof points, sharpening investment, and resource allocation
- Prioritizing indications and modalities where in vivo approaches add differentiated value alongside existing assets, focusing pipeline sequencing
- Aligning global development routes, data portability, and CMC readiness with near-term regulatory and commercial realities, accelerating time to value
